News

An infection preventionist examines the DRC’s Ebola response through contact tracing and community engagement, explaining why daily follow-up, timely investigations, and trust reveal challenges that cumulative case counts alone cannot capture.

Four vaccine experts discuss how sustained financing, local research leadership, and community trust can strengthen vaccine development in low- and middle-income countries (LMICs), drawing on practical insights from India and Bangladesh.

GeoVax CEO David Dodd discusses how vaccine storage requirements, supplier diversification, and regional manufacturing shape outbreak preparedness, with considerations for infection preventionists and health systems preparing to receive and administer doses.

Part 4 of 4: Why better planning for surgical growth, operational performance, and patient safety requires sterile processing expertise early in the decision-making process.

An emerging cause of sexually transmitted ringworm, TMVII can resemble other skin conditions and require prolonged treatment. Learn what clinicians and infection preventionists should know about recognition, specialized testing, and patient counseling.

3 of 4: How technology, artificial intelligence, automation, and data are reshaping sterile processing leadership

Part 2 of 4: Recruitment may bring people into sterile processing. Development is what determines whether they stay.

At IDWeek 2026, Rachel Sidebottom discusses research exploring phage-antibiotic combinations, the potential for predictive modeling, and an investigation identifying an ST5 strain of nontoxigenic Corynebacterium diphtheriae circulating in Albuquerque.

Finding infections earlier is only part of the work. At IDWeek 2026, David Weber, MD, MPH, explored how broader surveillance and emerging technologies could help infection preventionists spend more time supporting safer care.

Part 1 of 4: How emerging sterile processing leaders are redefining leadership through trust, accountability, psychological safety, and professional development.

This week in infection prevention: Kenya’s Bundibugyo virus response shows why execution, not just planning, determines outcomes, and France reported the first known human Shamonda virus infection. Our roundup also covers brucellosis, blood donor screening, and long-acting HIV antibody findings from IDWeek 2026.

At IDWeek 2026, Jimmy Chang, PhD, discussed investigational HIV antibodies TMB-365 and TMB-380, explaining their complementary mechanisms, early study findings, and ongoing evaluation as a long-acting maintenance regimen.

At IDWeek 2026, Samuel Ntow, MBChB, MPH, discussed research findings of reactive infection screening markers in 18.3% of replacement donor records from rural Ghana, highlighting opportunities for further evaluation and linkage to care.

France’s first reported human Shamonda virus infection raises questions about transmission and vulnerable patients. Explore what investigators know, what remains uncertain, and why infection preventionists should follow this emerging story.

John Rex, MD, CMO of F2G, discusses investigational olorofim’s phase 3 findings, why new antifungals are difficult to develop, and how an oral option could help patients with limited treatment choices.

An analysis of 147 million US hospital admissions identified 875 adults with brucellosis diagnoses, highlighting demographic and regional differences while emphasizing exposure histories and uncertainty about underdiagnosis.

Kenya’s secondary Ebola cases raise urgent questions about hospital readiness. Explore what the response reveals about contact tracing, health care worker protection, and the implementation of infection prevention plans.

An ICU study found that alcohol-based hand rub applied after patient care reduced glove bioburden, while staff raised feasibility concerns. Researchers stress that the practice does not replace glove changes or hand hygiene.

A study of 4,851 nursing home residents linked shared rooms to higher odds of matching MDRO carriage, while universal decolonization was associated with lower concordant carriage across MRSA, ESBL, and VRE.

A retrospective hospital study found no significant differences in mortality or readmissions between infectious disease e-consults and in-person consultations, despite more diagnoses of bacteremia among e-consult patients. Researchers recommend further evaluation across settings.

Presented at IDWeek 2026, a living review of 64 studies found the strongest evidence for dengue prevention from mosquito modification, while highlighting substantial uncertainty and research gaps in other approaches to Aedes vector control.

A 2026 IDWeek poster details how respiratory cultures and whole genome sequencing clarified a NICU MRSA outbreak, with targeted prevention measures followed by at least 6 months without additional bacteremias or related respiratory clusters.

Researchers recovered a carbapenemase-producing organism from the shaft of a hospital drain auger, prompting calls for standardized reprocessing protocols and further investigation into maintenance equipment as a potential source of environmental dissemination.

A poster presented at IDWeek was a systematic review of 35 studies that found rare transmission of viral hemorrhagic fever to health care personnel in high-income countries and highlighted the need for standardized exposure definitions to guide response.

Kimberley Brown, PharmD, Head of U.S. Medical Affairs at ViiV Healthcare discusses the evolution of HIV care and how innovative long-acting injectables are expanding options across HIV treatment and prevention.

Clean Hospitals President Alexandra Peters, PhD, explains how training, meaningful support, and stronger collaboration with infection prevention teams can empower environmental services staff and strengthen patient safety.

A proposed hepatitis B vaccine trial in Guinea-Bissau raises concerns about delaying newborn protection. This commentary examines the ethical obligations of researchers and the consequences of weakening established prevention efforts.

For International Infection Prevention Week, Infection Control Today explores how prevention connects hospital departments with everyday community life and why infection preventionists (IPs), sterile processing department (SPD), professionals, and environmental services (EVS) teams deserve lasting support.